ArticleJournal of hematology & oncology2024

Long-term survival with donor CD19 CAR-T cell treatment for relapsed patients after allogeneic hematopietic stem cell transplantation.

Cheng Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.